Nan Shan Life Insurance’s Lam Research LRCX Stock Holding History

Nan Shan Life Insurance’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.95M	Buy	+46,575	New	+$10.4M	0.36%	59
2020 Q3	–	Sell	-130,000	Closed	-$4.21M	–	113
2020 Q2	$4.21M	Sell	130,000 -497,000	-79%	-$13.6M	0.13%	83
2020 Q1	$15M	Buy	+627,000	New	+$18.1M	0.55%	49
2017 Q4	–	Sell	-9,462,930	Closed	-$175M	–	87
2017 Q3	$175M	Buy	9,462,930 +8,966,930	+1,808%	+$145M	3.62%	9
2017 Q2	$7.01M	Sell	496,000 -2,112,770	-81%	-$31M	0.18%	48
2017 Q1	$33.5M	Buy	+2,608,770	New	+$30.7M	0.83%	35

Other funds holding LRCX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nan Shan Life Insurance's LRCX Position: Q1 2026 in Review

Nan Shan Life Insurance opened a new position in Lam Research (LRCX) in Q1 2026: 46,575 shares worth $9.95M. The stake represents 0.36% of the portfolio and ranks #59 among its holdings. This is a return to the name: Nan Shan Life Insurance previously reported a position in LRCX as recently as Q2 2020.

Nan Shan Life Insurance first reported a position in LRCX in Q1 2017 and has held it in 6 quarters since. The position peaked at $175M in Q3 2017. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

Nan Shan Life Insurance held 46,575 shares of Lam Research worth $9.95M as of Q1 2026.
Lam Research was a new Nan Shan Life Insurance position in Q1 2026.
Lam Research made up 0.36% of Nan Shan Life Insurance's portfolio in Q1 2026, its #59 holding.
Nan Shan Life Insurance first reported a position in Lam Research in Q1 2017 and has held it in 6 quarters since.
Nan Shan Life Insurance's Lam Research position peaked at $175M in Q3 2017.
2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on Nan Shan Life Insurance's 13F filing for Q1 2026, filed 14 May 2026.